NanoView Biosciences to Present at the Biotech Showcase™ Annual Conference on January 14, 2020

BOSTON--()--NanoView Biosciences, Inc., today announced that Jerry Williamson, Chief Executive Officer, is scheduled to present at Biotech Showcase™ 2020 taking place on January 13-15, 2020 at the Hilton San Francisco Union Square, San Francisco, CA. NanoView’s proprietary product, the ExoView™ system, enables life science researchers to better understand the biological role of exosomes. For more information on the company and images please click here.

Details for the presentation are as follows:

Date: January 14, 2020

Time: 3:45 pm PST

Room: Hilton/Franciscan D, Ballroom Level

Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA

The ExoView platform is designed For Research Use Only. It is not for use in diagnostic procedures.

About NanoView Biosciences

NanoView Biosciences, a Boston-based, privately-held company, is focused on enabling life science researchers to better understand the biological role of exosomes and their potential use as biomarkers for improving the diagnosis, prognosis, treatment, and monitoring of disease. The company’s proprietary product, the ExoView™ platform, was designed to fully characterize exosomes and other extracellular vesicles for use in research and in the implementation of precision medicine. ExoView is a high-throughput, cost-effective analysis platform that is easy to use and does not require purification or large sample volumes to accurately analyze exosomes.

www.nanoviewbio.com

Contacts

Michelle Linn
Bioscribe
Phone: 774-696-3803
Email: michelle@bioscribe.com

Release Summary

NanoView to present at Biotech Showcase™ 2020 on January 14 at the Hilton San Francisco Union Square.

Contacts

Michelle Linn
Bioscribe
Phone: 774-696-3803
Email: michelle@bioscribe.com